Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Izotropic Corp C.IZO

Alternate Symbol(s):  IZOZF

Izotropic Corporation is a Canada-based medical device company. The Company is engaged in the development and commercialization of IzoView, a computed tomography (CT) imaging system, which produces cross-sectional images that can be imaged in the 30 centi-meter aperture by computer reconstruction of x-ray transmission data for non-invasive visualization of tissue. The IzoView is for use in the non-invasive visualization of breast tissue, as an adjunct tool to mammography, by providing x-ray computer reconstructed images as an aid for qualified healthcare providers. The Company has not generated any revenue.


CSE:IZO - Post by User

Post by wallpaper2on Oct 29, 2020 1:52pm
170 Views
Post# 31804471

Have you read the MD&As and quarterlies etc.

Have you read the MD&As and quarterlies etc.The company was put together by issuing 20 million shares at approx 51/2 cents each. PP's with  shares, attached warrants and stock options took the number of shares outstanding to 29.999 million approx On Sept. 24th there were approx. 30,3 million shs outstanding [shs o/s]
As I read it, on Sept 24th and Oct 20th PP's, options to management etc. and warrants issued have taken the fully diluted total of shs o/s to approx. 51 million. Most of these follow up shares were issued between 20-55 cents.
My point is:  they have hired 3 different IR or promotion companies to help them sell stock and get the word out. They say the testing and trials won't be complete until May 2022 at the earliest and they have given themselves an addition 5 years beyond that to complete the trials because of covid and the potential disruption to the economy.  Be careful with your excitement and don't get too far ahead of yourselves. You are buying someones cheap stock and some of that easy profit will go into the next below market pp. jmho
<< Previous
Bullboard Posts
Next >>